Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-10 Purchase |
2023-11-13 5:24 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
17,000 | $9.879 | $167,943 | 144,389 (Direct) |
View |
| 2023-11-07 Purchase |
2023-11-09 5:02 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
199,601 | $7.1893 | $1,434,987 | 350,339 (Indirect Direct) |
View |
| 2023-10-03 Purchase |
2023-10-05 7:56 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
20,066 | $8.3811 | $168,175 | 225,738 (Indirect Direct) |
View |
| 2023-01-05 Purchase |
2023-01-09 5:55 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
2,000 | $10.41 | $20,811 | 18,000 (Indirect) |
View |
| 2022-12-28 Purchase |
2022-12-30 7:01 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
4,000 | $9.75 | $39,000 | 17,000 (Indirect) |
View |
| 2022-12-01 Purchase |
2022-12-15 6:15 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
10,000 | $12.37 | $123,700 | 15,000 (Indirect) |
View |
| 2022-06-10 Purchase |
2022-06-14 9:29 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
50,000 | $14.33 | $716,300 | 40,000 (Indirect Direct) |
View |
| 2021-10-04 Sale |
2021-10-04 9:15 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
12,896 | $66.35 | $855,588 | 80,959 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-05 7:54 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
12,897 | $43.5 | $561,021 | 88,855 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-20 Option Award |
2024-06-24 4:05 pm |
N/A 2034-06-20 |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
25,000 | $0 | 450,339 (Direct) |
View |
| 2024-06-21 Option Award |
2024-06-21 5:07 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
48,429 | $0 | 192,818 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-16 5:04 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
19,059 | $0 | 127,389 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:56 pm |
N/A 2033-06-07 |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:07 pm |
N/A 2032-06-15 |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
16,000 | $0 | 205,672 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:22 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
24,871 | $0 | 108,330 (Direct) |
View |
| 2021-06-04 Option Award(A) |
2021-12-17 5:57 pm |
N/A 2031-06-03 |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
30,000 | $0 | 118,855 (Direct) |
View |
| 2021-11-02 Conversion |
2021-11-02 4:11 pm |
N/A N/A |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
139,672 | $0 | 139,672 (Indirect) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:33 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
24,000 | $0 | 24,000 (Direct) |
View |
Ownership |
2021-10-28 8:22 pm |
N/A N/A |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
0 | $0 | 460,839 (Indirect) |
View |
| 2021-06-04 Option Award |
2021-06-08 5:26 pm |
N/A 2031-06-03 |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
20,000 | $0 | 108,855 (Direct) |
View |